| Current Price | $84.84 | Mkt Cap | $174.2B |
|---|---|---|---|
| Open | $83.94 | P/E Ratio | 19.59 |
| Prev. Close | $84.84 | Div. (Yield) | $2.08 (2.5%) |
| Daily Range | $83.77 - $85.32 | Volume | 10,121 |
| 52-Wk Range | $77.04 - $98.52 | Avg. Daily Vol. | 2,040,604 |
Operates in the business of patent-protected and generic pharmaceuticals as well as consumer health products.
| Current Price | $84.84 | Mkt Cap | $174.2B |
|---|---|---|---|
| Open | $83.94 | P/E Ratio | 19.59 |
| Prev. Close | $84.84 | Div. (Yield) | $2.08 (2.5%) |
| Daily Range | $83.77 - $85.32 | Volume | 10,121 |
| 52-Wk Range | $77.04 - $98.52 | Avg. Daily Vol. | 2,040,604 |
The best Bull and Bear pitches based on recency and number of recommendations.
Dividend, M & A activity, and pipeline.
After a good run in the past couple months, NVS looks poised to underperform the S&P. Not that I think its going to take a fall, more so that the S&P will be playing catchup for the next couple of months while NVS hangs around somewhat.
Read the most recent pitches from players about NVS.
Recs
TMFkodyk123
(31.75)
Submitted: 9/22/2021 4:16:06 PM :
Start Price:
$83.56
NYSE:NVS Score:
-2.14
Novartis has numerous fast-growing drugs, which is why analysts are expecting 8% annual earnings growth over the next five years. At just 13 times this year's earnings, Novartis is reasonably priced. That's why I expect the stock will outperform the S&P 500 in the next 5-10 years.
Recs
jbswen
(< 20)
Submitted: 3/27/2020 2:10:51 PM :
Start Price:
$79.17
NYSE:NVS Score:
-70.93
With this epidemic and once the find a cure they are for sure to take off
Recs
XMFmarkprvulovic
(< 20)
Submitted: 10/17/2019 4:21:14 AM :
Start Price:
$82.06
NYSE:NVS Score:
-53.98
Growing revenues among most major drugs, with its top therapy seeing an impressive 23% increase in quarterly revenue. Updated clinical results for breast cancer drug are also highly impressive.
Find the members with the highest scoring picks in NVS.
wcwhiner (27.42) Score: +249.83
The Score Leader is the player with the highest score across all their picks in NVS.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| wcwhiner | 27.42 | 4/28/2009 |
|
NS | $27.73 | +205.97% | +435.88% | +229.91 | 0 Comment | |
| Bankwatcher1 | 24.25 | 10/7/2008 |
|
NS | $38.28 | +121.61% | +342.87% | +221.26 | 0 Comment | |
| BridgeTech | < 20 | 5/29/2009 |
|
3Y | $29.84 | +184.30% | +404.04% | +219.74 | 0 Comment | |
| Spelunkin | 26.42 | 11/2/2009 |
|
5Y | $38.67 | +119.39% | +337.92% | +218.54 | 0 Comment | |
| PurePwnage | 98.23 | 11/27/2009 |
|
5Y | $41.02 | +106.84% | +320.67% | +213.83 | 0 Comment | |
| TrackDuality | < 20 | 11/6/2009 |
|
5Y | $39.09 | +117.04% | +329.15% | +212.11 | 0 Comment | |
| Gratta | < 20 | 8/18/2009 |
|
5Y | $33.16 | +155.86% | +365.02% | +209.16 | 1 Comment | |
| 39272x0 | 37.73 | 12/2/2009 |
|
5Y | $42.06 | +101.70% | +309.79% | +208.09 | 0 Comment | |
| kaChingkaChing | 37.87 | 12/2/2009 |
|
3W | $42.06 | +101.70% | +309.79% | +208.09 | 0 Comment | |
| DiamondDawg | 90.60 | 11/25/2009 |
|
5Y | $41.69 | +103.51% | +310.19% | +206.69 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
